comparing axi-cel and tisa-cel in b-cell lymphomas
Published 2 years ago • 213 plays • Length 1:38Download video MP4
Download video MP3
Similar videos
-
2:44
comparing car-t products for aggressive b-cell lymphoma: axi-cel versus tisa-cel
-
1:36
real-world comparison of axi-cel and tisa-cel in r/r dlbcl
-
4:20
differential dynamics of response between axi-cel and tisa-cel in r/r b-cell lymphoma
-
1:45
matched comparison of tisa-cel and axi-cel in r/r dlbcl
-
1:17
choosing between tisa-cel, liso-cel & axi-cel in lbcl
-
3:21
comparing the efficacy of tisa-cel and axi-cel in patients with r/r fl
-
0:56
real-world data comparing the efficacy and safety of axi-cel & tisa-cel in dlcbl
-
6:28
cytoquest™ cr ctc enrichment - rbc lysis
-
![mixed leukocyte reaction and other antigen-presentation assays [webinar]](https://i.ytimg.com/vi/vCt7JToKeMk/mqdefault.jpg)
18:55
mixed leukocyte reaction and other antigen-presentation assays [webinar]
-
22:20
the blueair filter problem
-
1:09
assessing cardiovascular tolerability of zanubrutinib vs ibrutinib in pts with b-cell malignancies
-
0:59
matching-adjusted indirect comparison of liso-cel vs axi-cel in the 2l treatment of r/r lbcl
-
1:31
liso-cel vs tisa-cel in third-line dlbcl treatment
-
2:18
matched-adjusted comparison of liso-cel versus axi-cel for the second-line treatment of r/r lbcl
-
2:45
the value of axi-cel as a second-line treatment in r/r lbcl
-
3:53
standard-of-care setting results of axi-cel in r/r large b-cell lymphoma
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
4:27
cytopenias after axi-cel in r/r large b-cell lymphoma: clinical implications
-
2:24
comparing allosct outcomes in secondary and de-novo acute lymphoblastic leukemia
-
1:58
comparing the safety & efficacy of reversible and irreversible btk inhibitors in cll
-
2:53
considering the sequencing of covalent and non-covalent btk inhibitors in cll